Related Experiment Video

Updated: Aug 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Vaccination and otitis media

P Karma1

  • 1Department of Otorhinolaryngology, Helsinki University Central Hospital, Helsinki, Finland. pekka.karma@hus.fi

ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|May 22, 2002
PubMed

Insights

New conjugate vaccines show promise in preventing bacterial acute otitis media (AOM) in infants. Further research is needed for vaccines against other common AOM pathogens like Haemophilus influenzae and Moraxella catarrhalis.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Acute otitis media (AOM) is a common childhood infection often caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • Previous attempts using pneumococcal capsular polysaccharide vaccines were unsuccessful in preventing AOM.
  • Developing effective vaccines against AOM remains a significant public health challenge.

Purpose of the Study:

  • To review the current status and future prospects of vaccine development for preventing acute otitis media.
  • To evaluate the efficacy of recent conjugate vaccines against pneumococcal AOM.
  • To discuss alternative strategies for AOM prevention, including those for non-encapsulated bacteria and viral causes.

Main Methods:

  • Review of clinical trials and scientific literature on AOM vaccines.
  • Analysis of immunogenicity and efficacy data for pneumococcal conjugate vaccines.
  • Exploration of ongoing vaccine development for Haemophilus influenzae and Moraxella catarrhalis.

Main Results:

  • A heptavalent pneumococcal CRM 197 conjugate vaccine demonstrated a 57% reduction in vaccine-type pneumococcal AOM episodes in infants.
  • Influenza vaccines have shown potential for preventing AOM during viral epidemics.
  • Passive immunoprophylaxis has not yet proven successful for AOM prevention.

Conclusions:

  • Pneumococcal conjugate vaccines represent a significant advancement in preventing AOM caused by specific Streptococcus pneumoniae serotypes.
  • Vaccine development for non-encapsulated Haemophilus influenzae and Moraxella catarrhalis is ongoing.
  • Future strategies may involve mucosal immunization and advancements in DNA and gene technology for AOM prevention.

More Related Videos

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...